Brochure
24 Sep 2025
Shamrock Master Portfolio
PDF 421 kB
Shamrock has a portfolio of 49 APIs, across 3 Shamrock Pharmagroup manufacturing sites, 7 Partner & Exclusive Manufacturing sites. Total volumes are 1475 KL
Content provided by our supplier
Shamrock Group
-
Country/Region:India
-
On CPHI since:2018
-
Certificates:2
-
Employees:250 - 499
Company types
Primary activities
Other Content from Shamrock Group (20)
-
Brochure Heparin & Enoxaparin Sodium API & FDF
LARGEST CONTRACT MANUFACTURING FOR HEPARIN SODIUM & ENOXAPARIN SODIUM IN INDIA Heparin Sodium Bovine Heparin Sodium Porcine Enoxaparin Sodium -
Brochure Biological Product Portfolio
EXTRACTED MATERIAL OF HUMAN & ANIMAL ORIGIN Crude, Intermediates, API, Finished Formulation (FDF) -
Brochure Unimark Remedies - Carbapenems
◦ Broad spectrum β-lactam antibiotics ◦ Leading developer of Carbapenems at USFDA compliant facility ◦ In-house production of Intermediates & Side Chains -
Brochure Company Presentation & Product Portfolio
API, Carbapenems, Intermediate, Biological and Formulation - Critical Care -
Brochure Drotaverine and Mebeverine.
Drotaverine is a phosphodiesterase-4 inhibitor used to alleviate gastrointestinal, genitourinary and smooth muscle spasms. Drotaverine is an antispasmodic drug. -
Brochure SHAMROCK COMPANY PROFILE
SHAMROCK COMPANY PROFILE -
Datasheet BIOLOGICAL APIS PRODUCT PORTFOLIO
BIOLOGICAL API PRODUCT PORTFOLIO -
Datasheet GLIPTINS LIST
GLIPTINS LIST -
Brochure Shamrock API Product List
Portfolio of Shamrock API -
Brochure Unimark API Product List
Portfolio of Unimark -
Brochure Veterinary API Product List
Veterinary API Product List
